Bunge Stock Could $134 by Year End, JPMorgan Analyst Says
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Stock indices provide benchmarks and a lens into market trends. This overview explains their purpose and how investors leverage them.
16,698 articlesJPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Rocket Lab rockets higher after a record Q1 FY2026 showing strong revenue and a bloated backlog, signaling momentum f...
A new Belden stake filed with the SEC shows an investment firm buying $89.5 million worth of shares. This article bre...
Apple hits a fresh 52-week high as Services revenue climbs and iPhone demand remains strong. The move fuels a buy, ho...
What if one Vanguard ETF could power your finances for decades? This guide explains why broad market exposure with VT...
A bold new plan could reshape crypto funding: a $300 million preferred stock sale to back an ETH-heavy treasury built...
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...
PayPal used to attract a premium multiple, but the growth narrative has cooled. This article breaks down the data, co...
A recent sale of 25,000 ALHC shares by Alignment Healthcare’s vice chairman has investors wondering about the stock’s...
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
A Fulton Financial director sold shares after the stock surged about 26%. This article breaks down what insider sales...
A large insider purchase by Conagra's CEO has investors buzzing. Learn what insider buying signals really mean, how t...